Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. arterial walls
Show results for
Products
Services

Companies


Refine by

Arterial Walls Articles & Analysis

9 news found

Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis

Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis

Specifically, the exquisite algorithms developed through machine learning characterize tissue types in the artery wall known to cause heart attacks, such as lipid rich necrotic core. ...

ByElucid


Alucent Biomedical Announces First Patient Enrolled in First in Human Natural Vascular Scaffolding Clinical Trial

Alucent Biomedical Announces First Patient Enrolled in First in Human Natural Vascular Scaffolding Clinical Trial

The therapy is designed to open vessels and maintain patency without the use of permanent implants for the treatment of peripheral artery disease (PAD) of the lower extremities. PAD, a painful and debilitating condition, affects more than 200 million people globally. The Alucent NVS Vessel Restoration System with Photoactivated Linking combines standard angioplasty with linking ...

ByAlucent Biomedical Inc.


Reflow Medical Enrolls First Patients In The DEEPER LIMUS Study Of The Temporary Spur Stent System

Reflow Medical Enrolls First Patients In The DEEPER LIMUS Study Of The Temporary Spur Stent System

Reflow Medical, Inc., a California-based medical device company, has enrolled the first patients in A Non-Randomized Pilot Study of the Temporary Spur Stent System for the Treatment of Lesions Located in the InfraPoplitEal Arteries Using a LIMUS-base Drug-coated Balloon (DEEPER LIMUS). The OUS single center clinical trial (NCT04162418) is expected to enroll up to 30 participants ...

ByReflow Medical, Inc.


Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial

Alucent Biomedical Announces First Patient Enrolled in Phase 1 Natural Vascular Scaffolding Clinical Trial

The therapy is designed to open vessels and keep them open without the use of permanent implants in the treatment of peripheral artery disease (PAD) of the lower extremities, a painful and debilitating condition affecting over 200 million people worldwide. The Alucent NVS Vessel Restoration System with Photoactivated Linking combines standard angioplasty with linking of the ...

ByAlucent Biomedical Inc.


Alucent Biomedical Announces FDA Approval to Proceed with Natural Vascular Scaffolding Clinical Trial

Alucent Biomedical Announces FDA Approval to Proceed with Natural Vascular Scaffolding Clinical Trial

The therapy is designed to treat peripheral artery disease (PAD) of the lower extremities, a painful and debilitating condition affecting over 200 million people worldwide. ...

ByAlucent Biomedical Inc.


Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration Developed at IU School of Medicine

Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration Developed at IU School of Medicine

According to the National Heart, Lung, and Blood Institute, one in 20 Americans older than age 50 has peripheral artery disease, or PAD. Often called "hardening of the arteries," the chronic condition develops when extra cholesterol in the bloodstream collects along the walls of arteries. ...

ByVascugen Inc.


CardioWise™ Acquires Worldwide Rights to Patent, and Software to Guide Cardiac Resynchronization Therapy Through License Agreement with Johns Hopkins Technology Ventures

CardioWise™ Acquires Worldwide Rights to Patent, and Software to Guide Cardiac Resynchronization Therapy Through License Agreement with Johns Hopkins Technology Ventures

The SQuEEZ technology is based on the ability to track the heart wall as it moves during the contraction of the heart to allow quantitative assessment of regional heart wall motion from cardiac CT data. The analysis can accurately quantify the regional heart wall motion of the left ventricle. SQuEEZ functional analysis is an essential component ...

ByCardioWise Inc.


FDA Clears Rex Medical Bioresorbable Vascular Closure Device

FDA Clears Rex Medical Bioresorbable Vascular Closure Device

It uses a patch placed against the artery wall and is secured on the outside of the vessel by an an attached suture connected to two spheres. ...

ByRex Medical, L.P.


Auto exhaust linked to increased risk of heart attack

Auto exhaust linked to increased risk of heart attack

Swiss, California and Spanish researchers have found that particulates from auto exhaust can lead to the thickening of artery walls, possibly increasing chances of a heart attack and ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT